095700.KQ
Genexine, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 2,165.00
−3.78%Year over year
Reported trailing growth
- Revenue
- +229.9%
- EBITDA
- +101.7%
- EBIT
- -15.4%
- EPS
- +58.0%
- Free cash flow
- -70.8%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -40.1%
- EBITDA
- —
- EPS
- +189.4%
Three-year CAGR
- Revenue
- -34.3%
- EBITDA
- +49.3%
- EBIT
- +3.2%
- Net income
- +57.6%
- EPS
- +60.7%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026